Home/Reveal Genomics/Joel Parker
JP

Joel Parker

Co-founder & CSO

Reveal Genomics

Therapeutic Areas

Reveal Genomics Pipeline

DrugIndicationPhase
HER2DX®HER2-positive Breast CancerCommercial